Abeona Therapeutics Inc. SEC filings ABEO
Abeona Therapeutics Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 21, 2008. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 17, 2024 | — |
| EFFECT | Filing | Dec 12, 2022 | — |
| CORRESP | Letter to the SEC | Dec 6, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2022 | — |
| EFFECT | Filing | Oct 22, 2021 | — |
| CORRESP | Letter to the SEC | Oct 19, 2021 | — |
| CORRESP | Letter to the SEC | Aug 30, 2021 | — |
| CORRESP | Letter to the SEC | Aug 27, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2021 | — |
| DEFR14A | Filing | Apr 19, 2021 | — |
| PX14A6G | Filing | Apr 29, 2020 | — |
| SEC STAFF LETTER | Filing | Mar 6, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 18, 2020 | — |
| 25-NSE | Delisting notice | Dec 20, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2019 | — |
| CORRESP | Letter to the SEC | Sep 20, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2019 | — |
| CORRESP | Letter to the SEC | Aug 20, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2019 | — |
| CT ORDER | Filing | Apr 3, 2019 | — |
| EFFECT | Filing | Jun 7, 2018 | — |
| CORRESP | Letter to the SEC | Jun 5, 2018 | — |
| RW | Filing | Mar 16, 2018 | — |
| EFFECT | Filing | May 3, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2017 | — |
| CORRESP | Letter to the SEC | Jan 25, 2017 | — |
| CORRESP | Letter to the SEC | Jan 4, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2016 | — |
| CT ORDER | Filing | Nov 15, 2016 | — |
| EFFECT | Filing | Sep 15, 2016 | — |
| EFFECT | Filing | Jul 23, 2015 | — |
| CORRESP | Letter to the SEC | Jul 23, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2015 | — |
| EFFECT | Filing | Jun 4, 2015 | — |
| CORRESP | Letter to the SEC | Jun 4, 2015 | — |
| D | Filing | Jun 1, 2015 | — |
| CORRESP | Letter to the SEC | Jun 1, 2015 | — |
| CORRESP | Letter to the SEC | May 29, 2015 | — |
| CORRESP | Letter to the SEC | May 26, 2015 | — |
| CORRESP | Letter to the SEC | May 26, 2015 | — |
| D | Filing | May 22, 2015 | — |
| UPLOAD | Letter from the SEC | May 19, 2015 | — |
| CT ORDER | Filing | Jan 5, 2015 | — |
| EFFECT | Filing | Dec 18, 2014 | — |
| CERTNAS | Auto-generated paper document | Nov 6, 2014 | — |
| 8-A12B | Filing | Nov 4, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2014 | — |
| CORRESP | Letter to the SEC | Sep 29, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2014 | — |
| PRER14A | Proxy statement amendment no. 1 | Apr 11, 2014 | — |
| CT ORDER | Filing | Oct 1, 2013 | — |
| D | Filing | Nov 2, 2012 | — |
| EFFECT | Filing | Apr 9, 2012 | — |
| EFFECT | Filing | Jan 20, 2012 | — |
| CORRESP | Letter to the SEC | Jan 19, 2012 | — |
| CORRESP | Letter to the SEC | Jan 17, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2011 | — |
| CORRESP | Letter to the SEC | Nov 16, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2011 | — |
| D | Filing | Nov 14, 2011 | — |
| CORRESP | Letter to the SEC | Oct 19, 2011 | — |
| CORRESP | Letter to the SEC | Oct 4, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2011 | — |
| EFFECT | Filing | Dec 8, 2010 | — |
| CORRESP | Letter to the SEC | Dec 7, 2010 | — |
| CORRESP | Letter to the SEC | Nov 23, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2010 | — |
| CORRESP | Letter to the SEC | Nov 15, 2010 | — |
| CORRESP | Letter to the SEC | Aug 24, 2010 | — |
| CORRESP | Letter to the SEC | Jul 9, 2010 | — |
| UPLOAD | Letter from the SEC | May 6, 2010 | — |
| EFFECT | Filing | Apr 29, 2010 | — |
| CORRESP | Letter to the SEC | Apr 27, 2010 | — |
| CORRESP | Letter to the SEC | Apr 26, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2010 | — |
| AW | Withdrawl of posteffective amendment | Apr 16, 2010 | — |
| AW | Withdrawal letter of posteffective amendment filed as s1/a | Apr 16, 2010 | — |
| AW | Withdrawal letter of posteffective amendment filed as s1/a | Apr 16, 2010 | — |
| AW | Post effective amendment #1 to form s1 | Apr 14, 2010 | — |
| AW | Post effective amendment s1 | Apr 14, 2010 | — |
| EFFECT | Filing | Jan 21, 2010 | — |
| NTN 10Q | Notification of late filing | May 15, 2009 | Mar 31, 2008 |
| NT 10-Q | Notification of late filing | May 15, 2009 | May 15, 2009 |
| EFFECT | Filing | Dec 11, 2008 | — |
| EFFECT | Filing | Nov 13, 2008 | — |
| CORRESP | Letter to the SEC | Nov 12, 2008 | — |
| CORRESP | Letter to the SEC | Oct 27, 2008 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2008 | — |
| CORRESP | Letter to the SEC | Oct 22, 2008 | — |
| CORRESP | Letter to the SEC | Oct 22, 2008 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2008 | — |
Showing 93 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABEO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cleveland, OH
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 318306
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC (until Jun 4, 2015); ACCESS PHARMACEUTICALS INC (until Aug 14, 2014); CHEMEX PHARMACEUTICALS INC (until Feb 5, 1996)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.